Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The 2018 WHO position paper on typhoid vaccines indicates preference for the use of new generation typhoid conjugate vaccines over existing parenteral Vi-polysaccharide (Vi-PS) and oral attenuated Ty21a vaccines

More information

DOI

10.1093/jtm/tay120

Type

Journal article

Publication Date

01/01/2018

Volume

25

Keywords

Humans, Mass Vaccination, Travel, Typhoid Fever, Typhoid-Paratyphoid Vaccines, Vaccines, Conjugate